Hiroyuki Yoshida
Hidaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
RECQL1 as a potential therapeutic target for PARP inhibitor-resistant ovarian cancer.
Journal: Scientific reports
Published: February 16, 2025
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 22, 2024
Declining Prevalence of Human Papillomavirus Co-Infections Among Young Japanese Women With Cervical Cancer and Its Precursors.
Journal: Journal of medical virology
Published: September 08, 2024
Age Is a Risk Factor for Olaparib Dose Modification and Discontinuation in Patients With Ovarian Cancer.
Journal: Cancer diagnosis & prognosis
Published: February 29, 2024
Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.
Journal: Cancer science
Published: April 20, 2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
Journal: JCO precision oncology
Published: January 30, 2023
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum-refractory/resistant ovarian cancer.
Journal: Cancer medicine
Published: December 23, 2022
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 26, 2022
Adenocarcinoma in situ or early-stage cervical cancer is a risk factor for preterm delivery after cervical conization: a multicenter observational study.
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Published: March 28, 2022
Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.
Journal: Japanese journal of clinical oncology
Published: January 06, 2022
Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.
Journal: Vaccines
Published: November 26, 2021
Last Updated: 09/26/2026